OGLOBE-GM2 SR
Each uncoated bilayered tablet contains : Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg (in sustained-release form) Voglibose IP 0.2 mg Excipients q.s.
OGLOBE-GM2 SR
| Composition | Each uncoated bilayered tablet contains : Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg (in sustained-release form) Voglibose IP 0.2 mg Excipients q.s. |
| Packing | BLISTER AMBER PVC - 10*10 |
| MRP | ₹1350.00000 |
| Manufacturer | COMMON |
| HSN Code | 30049099.0 |
Product image not available
PCD Franchise Opportunity
Request This Product
Get bulk pricing, MOQ, and franchise availability for OGLOBE-GM2 SR.
Related Products
More products in the DIABETIC therapeutic category
Metcian 1000
Each uncoated sustained release tablet contains : Metformin Hydrochloride IP 1000 mg Excipients q.s.
BLISTER CLEAR PVC - 10*10
GEPIOZ V
Each film coated tablet contains: Vildagliptin IP 50mg Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15mg Excipients q.s.
ALU ALU - 6*15
METCIAN
Each uncoated tablet contains: Metformin Hydrochloride IP 500mg Excipients q.s.
BLISTER ORANGE PVC - 20*10
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.